CONCLUDE - A new treatment for Left-sided Ulcerative Colitis

Moderately to severely active Left-sided Ulcerative Colitis

The purpose of this study is to learn about the safety and effectiveness of an investigational drug called Cobitolimod in the treatment of ulcerative colitis.

Category
Trial Status
Recruiting
Trial Phase
Phase 3 Drug Trial
Trial contact details
Contact Person
IBD Clinical Trials Unit
What you need to know

Who can take part?

  • People aged 18 – 75
  • Confirmed diagnosis of mild to moderate Ulcerative Colitis at least 12 weeks prior to joining the study
  • Willingness to complete a daily diary
  • Dosage of any current medications for ulcerative colitis are stable

Exclusions

  • People aged 18 – 75
  • Confirmed diagnosis of mild to moderate Ulcerative Colitis at least 12 weeks prior to joining the study
  • Willingness to complete a daily diary
  • Dosage of any current medications for ulcerative colitis are stable

What is involved for you?

  • Medical history and collection of demographic information
  • Vital signs
  • Electrocardiogram
  • Physical exam
  • Blood and urine tests
  • Pregnancy tests for women of childbearing potential
  • Colonoscopy and biopsy
  • Daily diary completion
  • Questionnaires
  • Periodic enemas

Trial dates

March 2023 - December 2023

All research clinical trials news

Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.

23

May

Mater launches trial of Australian-first flu vaccine

Stephanie Guilas has worked in many departments throughout Mater Hospital Brisbane, however, after 28 years of service, she found her true passion working within Mater Research’s Mothers and Babies...

19

May

Stephanie Guilas is improving outcomes for mums and bubs through research

Working as a research assistant in an immunology research lab, Yvonne Gautam learnt what a clinical trial was after being asked to set up a lab for a Phase Two clinical trial.

18

May

Clinical Trials Coordinator Yvonne Gautam is working towards creating better treatments for patients with diabetes

Displaying results 1-3 (of 16)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|